Evaluating the Schematic Assessment of Impact of Glycaemic Control on Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus, A Systematic Review and Meta-Analysis

Authors

  • Uday Shree Akkala Shetty Southern Regional Medical Center, Riverdale, Georgia, USA.
  • Muhammad Zaman Baloch Indus Medical College, The University of Modern Science, TMK, Pakistan.
  • Mustafa Duraab Kalwar Karachi Grammar School, Karachi, Pakistan.
  • Kainat Zafar Akhtar Saeed Medical College, Akhtar Saeed Hospital, Lahore, Pakistan. https://orcid.org/0009-0000-4567-8833

DOI:

https://doi.org/10.36283/ziun-pjmd15-2/030

Keywords:

Diabetic Neuropathies, Diabetes Mellitus, Diabetes Mellitus Type 2, Valsalva Maneuvers, Heart Rate, Glycaemic Control, Percutaneous Coronary Intervention

Abstract

Background: Cardiac autonomic neuropathy (CAN) is a severe, poorly known complication of type 2 diabetes mellitus (T2DM), which is the loss of autonomic control of heart rate and blood pressure and is linked to morbidity and mortality. This meta-analysis and systematic review aimed to determine the effect of interventional measures on the cardiac autonomic function of patients with type 2 diabetes mellitus (T2DM).

Methods: An extensive search in PubMed, Scopus, Web of Science, and Google Scholar until November 2025 was conducted. The randomized controlled trials, the prospective cohort studies, and the observational studies that measure cardiac autonomic functioning in patients with T2DM were covered. Risk of bias of the included observational and interventional studies was assessed using the Newcastle–Ottawa Scale (NOS) for cohort and cross-sectional studies, and the Cochrane ROB tool for randomized trials; and the degree of certainty of evidence was gauged through the GRADE method.

Results: 12 studies passed the inclusion criteria. The meta-analysis of both primary outcomes; E: I ratio and Valsalva ratio showed no statistically significant improvements, respectively. There was a high heterogeneity (I2 = 95-98%), which could probably be explained by the variation in the nature of patients, types of interventions, and protocols of measurement. The rigor of findings was ensured by subgroup and sensitivity analysis.

Conclusion: T2DM patients have mixed effects on cardiac autonomic functioning in terms of interventions. Non-pharmacological and multimodal approaches have the potential to be of value, particularly in optimal glycaemic control, yet standardized trials are needed to offer certain directions.

Author Biographies

  • Uday Shree Akkala Shetty, Southern Regional Medical Center, Riverdale, Georgia, USA.

    Department of Internal Medicine 

  • Muhammad Zaman Baloch, Indus Medical College, The University of Modern Science, TMK, Pakistan.

    Department of Cardiology, 

  • Mustafa Duraab Kalwar, Karachi Grammar School, Karachi, Pakistan.

    Department of Pre-Medical, 

  • Kainat Zafar, Akhtar Saeed Medical College, Akhtar Saeed Hospital, Lahore, Pakistan.

    Department of Pathology

References

1.Soe KK, Selvarajah D. Cardiac Autonomic Neuropathy and Its Impact on Progression of Diabetic Kidney Disease in Type 1 and Type 2 Diabetes. Kidney Med 2025;7:101149. doi:10.1016/j.xkme.2025.101149

2.Gogan A, Potre O, Avram V-F, Andor M, Caruntu F, Timar B, et al. Cardiac Autonomic Neuropathy in Diabetes Mellitus: Pathogenesis, Epidemiology, Diagnosis and Clinical Implications: A Narrative Review. J Clin Med 2025;14. doi:10.3390/jcm14030671

3.Damoun N, Amekran Y, Taiek N, Hangouche AJE. Heart rate variability measurement and influencing factors: Towards the standardization of methodology. Glob Cardiol Sci Pract 2024:e202435. doi:10.21542/gcsp.2024.35

4.Duque A, Mediano MFF, De Lorenzo A, Rodrigues LF Jr. Cardiovascular autonomic neuropathy in diabetes: Pathophysiology, clinical assessment and implications. World J Diabetes 2021;12:855–67. doi:10.4239/wjd.v12.i6.855

5.Ashinze P, Gaur A, Banerjee S, Olaniyan OM, Akande E, Idris-Agbabiaka A, et al. The role of heart rate variability in cardiac surgery: applications and innovations. Cardiothorac Surg 2025;33:34. doi:10.1186/s43057-025-00179-9

6.Míková M, Pospíšil D, Řehoř J, Malik M. Heart Rate Variability Analysis in Congestive Heart Failure: The Need for Standardized Assessment Protocols. Rev Cardiovasc Med 2025;26:36321. doi:10.31083/RCM36321

7.John APP, Udupa K, Avangapur S, Sujan MU, Inbaraj G, Vasuki PP, et al. Cardiac autonomic dysfunctions in type 2 diabetes mellitus: an investigative study with heart rate variability measures. Am J Cardiovasc Dis 2022;12:224–32.

8.Al-Ozairi E, Jallo MK, Hafidh K, Alhajeri DM, Ashour T, Mahmoud EFN, et al. Prevalence of Cardiovascular and Renal Co-morbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational Study. Diabetes Ther 2021;12:1193–207. doi:10.1007/s13300-021-01038-6

9.Gieroba B, Kryska A, Sroka-Bartnicka A. Type 2 diabetes mellitus – conventional therapies and future perspectives in innovative treatment. Biochem Biophys Rep 2025;42:102037. doi:10.1016/j.bbrep.2025.102037

10.Bhat S, Yatsynovich Y, Sharma UC. Coronary revascularization in patients with stable coronary disease and diabetes mellitus. Diab Vasc Dis Res 2021;18:14791641211002469. doi:10.1177/14791641211002469

11.Zhang W, Bi S, Luo L. The impact of long-term exercise intervention on heart rate variability indices: a systematic meta-analysis. Front Cardiovasc Med 2025;12:1364905. doi:10.3389/fcvm.2025.1364905

12.Zaki S, Alam MF, Sharma S, El-Ashker S, Ahsan M, Nuhmani S, et al. Impact of Concurrent Exercise Training on Cardiac Autonomic Modulation, Metabolic Profile, Body Composition, Cardiorespiratory Fitness, and Quality of Life in Type 2 Diabetes with Cardiac Autonomic Neuropathy: A Randomized Controlled Trial. J Clin Med 2024;13. doi:10.3390/jcm13133910

13.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. doi:10.1136/bmj.n71

14.metaanalysisonline.com. [Internet]. 2025 [cited 2025 Oct 19]. Available from: https://metaanalysisonline.com/

15.Nganou-Gnindjio CN, Mba CM, Azabji-Kenfack M, Dehayem MY, Mfeukeu-Kuate L, Mbanya J-C, et al. Poor glycemic control impacts heart rate variability in patients with type 2 diabetes mellitus: a cross sectional study. BMC Res Notes 2018;11:599. doi:10.1186/s13104-018-3692-z

16.Moshenets K, Pertseva N. The impact of glycemic control on heart rate variability in patients with type 2 Diabetes Mellitus and the potential for prediction. Romanian J Diabetes Nutr Metab Dis 2024;31:441–7.

17.Subbalakshmi NK, Adhikari P, Shanmugavel Jeganathan P. Comparative study on cardiac autonomic modulation during deep breathing test and diaphragmatic breathing in type 2 diabetes and healthy subjects. J Diabetes Investig 2014;5:456–63. doi:10.1111/jdi.12163

18.Memon A. Cardiac autonomic neuropathy in type 2 diabetes mellitus using Bellavere’s score system. Int J Health Sci 2017;11:26–9.

19.Kuriakose S, Singhal A, Bansal N, Shukla R, Paul SM, Singhal A. A Study on Autonomic Dysfunction in Type 2 Diabetes Mellitus with Peripheral Neuropathy. J Mar Med Soc 2025;27:24. doi:10.4103/jmms.jmms_6_24

20.Raje S, Maiya GA, R P, Prabhu MA, Nayak K, Shivashankara KN, et al. Prediction of cardiac autonomic dysfunction using heart rate response to deep breathing test among type 2 diabetes mellitus. BMC Endocr Disord 2025;25:117. doi:10.1186/s12902-025-01939-8

21.Felício JS, Araújo MAM, de Lemos GN, Fernandes IJ, Ruivo LO, Chambouleyron EG, et al. Heart rate variability tests for diagnosing cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus in advanced stages of kidney disease. Cardiovasc Diabetol 2025;24:144. doi:10.1186/s12933-025-02666-z

22.Jayabal M, Kumar Selvaraj V, Subramaniam M, Shivalingiaya J, Ramanathan R. Classical autonomic function tests in type 2 diabetes mellitus patients with different HbA1c levels: A comparative study. Indian J Clin Anat Physiol 2019;6:23–6. doi:10.18231/2394-2126.2019.0006

23.Zeng H, Liu J, Chen Z, Yu P, Liu J. Cardiac Autonomic Dysfunction Is Associated With Risk of Diabetic Kidney Disease Progression in Type 2 Diabetes Mellitus. Front Endocrinol 2022;13:900465. doi:10.3389/fendo.2022.900465

24.Ahmed TS, Al-Maatouq MA, Al-Tuwaijri AS. Subclinical autonomic neuropathy in Saudi type 2 diabetic patients. 12

25.Xuan M, Shen Y, Tang W, Fang P, Liu G, Li G, et al. Effect of slow deep breathing on cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients. Diabetol Metab Syndr 2025;17:330. doi:10.1186/s13098-025-01862-x

26.Alauddin W, Radke PM, Pardhi P, Mishra M, Arora S. Effects of Revascularization on Cardiac Autonomic Neuropathy in Type 2 Diabetes Mellitus Patients With Chronic Stable Angina. Cureus 2024;16:e72278. doi:10.7759/cureus.72278

27.Yang Y, Zhao B, Wang Y, Lan H, Liu X, Hu Y, et al. Diabetic neuropathy: cutting-edge research and future directions. Signal Transduct Target Ther 2025;10:132. doi:10.1038/s41392-025-02175-1

28.Mehra R, Tjurmina OA, Ajijola OA, Arora R, Bolser DC, Chapleau MW, et al. Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From the National Heart, Lung, and Blood Institute and the National Institutes of Health Office of the Director Workshop. JACC Basic Transl Sci 2022;7:265–93. doi:10.1016/j.jacbts.2021.11.003

29.Kaze AD, Fonarow GC, Echouffo-Tcheugui JB. Cardiac Autonomic Dysfunction and Risk of Silent Myocardial Infarction Among Adults With Type 2 Diabetes. J Am Heart Assoc 2023;12:e029814. doi:10.1161/JAHA.123.029814

30.Zilliox LA, Russell JW. Is there cardiac autonomic neuropathy in prediabetes? Auton Neurosci 2020;229:102722. doi:10.1016/j.autneu.2020.102722

31.Oliveira DPSC, Souza QS, Facchin AC, Mariano BC, Silva LP, Peçanha T. Diagnostic value of heart rate-based methods for assessing cardiac autonomic neuropathy in prediabetes and diabetes. Physiol Rep 2025;13:e70610. doi:10.14814/phy2.70610

32.Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, et al. Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways. Cureus 15:e45835. doi:10.7759/cureus.45835

33.Espinoza-Salinas A, Molina-Sotomayor E, Cano-Montoya J, Gonzalez-Jurado JA, Espinoza-Salinas A, Molina-Sotomayor E, et al. Is Active Lifestyle Related to Autonomic Nervous System Function and Lipid Profile in People with Overweight? A Study Pilot. Sustainability 2021;13. doi:10.3390/su13052439

34.Kulkarni A, Thool AR, Daigavane S. Understanding the Clinical Relationship Between Diabetic Retinopathy, Nephropathy, and Neuropathy: A Comprehensive Review. Cureus 2024;16:e56674. doi:10.7759/cureus.56674

35.Thal SC, Shityakov S, Salvador E, Förster CY, Thal SC, Shityakov S, et al. Heart Rate Variability, Microvascular Dysfunction, and Inflammation: Exploring the Potential of taVNS in Managing Heart Failure in Type 2 Diabetes Mellitus. Biomolecules 2025;15. doi:10.3390/biom15040499

36.Liu X, Shan Z, Shen T, Lo M, Luo L, Sun Q, et al. Individualized paced deep breathing training with autonomic nervous function as rehab targets in patients with chronic heart failure: a randomized clinical trial. Int J Cardiol Heart Vasc 2025;61:101800. doi:10.1016/j.ijcha.2025.101800

37.Abubakar M, Javed I, Rasool HF, Raza S, Basavaraju D, Abdullah RM, et al. Advancements in Percutaneous Coronary Intervention Techniques: A Comprehensive Literature Review of Mixed Studies and Practice Guidelines. Cureus 15:e41311. doi:10.7759/cureus.41311

38.Obaya HE, Abdeen HA, Salem AA, Shehata MA, Aldhahi MI, Muka T, et al. Effect of aerobic exercise, slow deep breathing and mindfulness meditation on cortisol and glucose levels in women with type 2 diabetes mellitus: a randomized controlled trial. Front Physiol 2023;14:1186546. doi:10.3389/fphys.2023.1186546

39.Bekker I, Kooistra A, van Dijk PR, Lefrandt JD, Veeger NJGM, van Beek AP. The Influence of Exercise and Physical Activity on Autonomic Nervous System Function Measured by Heart Rate Variability in Individuals with Type 1 Diabetes Mellitus—A Systematic Review. Int J Mol Sci 2025;26:7096. doi:10.3390/ijms26157096

40.Nabrdalik K, Kwiendacz H, Moos J, Moos Ł, Kulpa J, Brzoza Z, et al. Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease: The Silesia Diabetes-Heart Project. Curr Probl Cardiol 2023;48:101726. doi:10.1016/j.cpcardiol.2023.101726

41.Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies AH, et al. Prevention and Management Strategies for Diabetic Neuropathy. Life 2022;12. doi:10.3390/life12081185

42.Almutairi M, Almutairi AA, Alodhialah AM, Almutairi M, Almutairi AA, Alodhialah AM. The Influence of Lifestyle Modifications on Cardiovascular Outcomes in Older Adults: Findings from a Cross-Sectional Study. Life 2025;15. doi:10.3390/life15010087

Published

2026-04-13

Metrics

How to Cite

1.
Shetty USA, Baloch MZ, Kalwar MD, Zafar K. Evaluating the Schematic Assessment of Impact of Glycaemic Control on Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus, A Systematic Review and Meta-Analysis. PJMD [Internet]. 2026 Apr. 13 [cited 2026 Jun. 3];15(2). Available from: https://ojs.zu.edu.pk/pjmd/article/view/4369

Similar Articles

31-40 of 531

You may also start an advanced similarity search for this article.